Skip to the content
Altai Oncology - Softwarelogo darklogo light
  • Library
  • Articles
  • Patient Education
  • F.A.Q.
  • Contact Us
Altai Oncology - Softwarelogo darklogo light
New Indication: Axitinib for Advanced Neuroendocrine Tumors
Altai Protocol Library

New Indication: Axitinib for Advanced Neuroendocrine Tumors

U. Darda Bayraktar, MD
2026-03-11
New Protocol: Neoadjuvant Docetaxel with Trastuzumab and Pertuzumab in HER2 + Breast Cancer
Altai Protocol Library

New Protocol: Neoadjuvant Docetaxel with Trastuzumab and Pertuzumab in HER2 + Breast Cancer

U. Darda Bayraktar, MD
2026-02-19
New Reference: Toripalimab with Chemotherapy for Advanced Esophageal SCC
Altai Protocol Library

New Reference: Toripalimab with Chemotherapy for Advanced Esophageal SCC

U. Darda Bayraktar, MD
2026-02-19
New Reference: Temozolomide for Anaplastic Glioma
Altai Protocol Library

New Reference: Temozolomide for Anaplastic Glioma

U. Darda Bayraktar, MD
2026-02-19
New Protocol: Sacituzumab Govitecan + Pembrolizumab for Triple-Negative Metastatic Breast Cancer
Altai Protocol Library

New Protocol: Sacituzumab Govitecan + Pembrolizumab for Triple-Negative Metastatic Breast Cancer

U. Darda Bayraktar, MD
2026-02-19
New Protocol: Lenvatinib with Bevacizumab for Gynecological Clear Cell Carcinoma
Altai Protocol Library

New Protocol: Lenvatinib with Bevacizumab for Gynecological Clear Cell Carcinoma

U. Darda Bayraktar, MD
2026-02-19
New Protocol: Letrozole and Palbociclib with Trastuzumab and Pertuzumab for Neoadjuvant Triple-Positive Breast Cancer
Altai Protocol Library

New Protocol: Letrozole and Palbociclib with Trastuzumab and Pertuzumab for Neoadjuvant Triple-Positive Breast Cancer

U. Darda Bayraktar, MD
2026-02-19
New Reference: Palbociclib Addition to Maintenance Therapy in Triple-Positive Breast Cancer
Altai Protocol Library

New Reference: Palbociclib Addition to Maintenance Therapy in Triple-Positive Breast Cancer

U. Darda Bayraktar, MD
2026-02-19
New Reference: Olaparib for PALB2 or BRCA1/2 Mutated Breast Cancer
Altai Protocol Library

New Reference: Olaparib for PALB2 or BRCA1/2 Mutated Breast Cancer

U. Darda Bayraktar, MD
2026-02-15
New Protocol: Ultra-Low Dose Nivolumab for Advanced Solid Tumors
Altai Protocol Library

New Protocol: Ultra-Low Dose Nivolumab for Advanced Solid Tumors

U. Darda Bayraktar, MD
2026-02-15

Posts pagination

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
  • Library
  • F.A.Q.
  • Contact Us

Privacy Policy

Altai, Inc (USA)

30 N Gould St, Ste 6801

Sheridan, WY, 82801, USA

Phone: +1 (978) 393 0042

Altay Tıp Sağlık Yazılım AŞ (Türkiye)

Mutlukent Mah Manuk Bey Sk No: 4

Çankaya, Ankara, 06800, Türkiye

Phone: +90 (312) 911 5735

Our Terms & Privacy Policy

Copyright - 2024 - Altai Inc - All rights reserved

Back to top Drag
  • Library
  • Articles
  • Patient Education
  • F.A.Q.
  • Contact Us

jghghjghjghhgj